공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

코골이 방지 치료 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Anti-Snoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 05월 상품 코드 659346
페이지 정보 영문
가격
US $ 4,250 ₩ 5,044,000 PDF (Single User License)
US $ 4,750 ₩ 5,637,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,121,000 PDF (Site License)
US $ 7,500 ₩ 8,901,000 PDF (Corporate License)


코골이 방지 치료 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Anti-Snoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 코골이 방지 치료(Anti-snoring Treatment) 시장을 조사했으며, 전체적인 시장 동향, 제품 및 지역별 동향, 시장 성장 영향요인, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

  • 시장 정의

제2장 조사 방법

제3장 주요 요약

제4장 주요 영향요인

제5장 시장 개요

  • 현재의 시장 시나리오
  • Porter's Five Forces 분석
    • 공급업체의 협상력
    • 소비자의 협상력
    • 신규 진출기업의 위협
    • 대체 제품과 서비스의 위협
    • 업계 내 경쟁
  • 규제 시나리오

제6장 성장 촉진요인 및 저해요인, 기회, 과제 분석(DROC)

  • 시장 성장 촉진요인
    • 비만과 고령자 인구 증가
    • 흡연과 알코올 소비 증가
    • 코골이 방지 기기의 기술적 발전
    • 선진국가에서의 인식 향상
  • 시장 성장 저해요인
    • 맞춤형 경구 기기의 높은 비용
    • 코골이 방지 기기의 유효성 부족과 과학적 분석 결여
    • 코골이에 관한 사회적 불명예
  • 시장 기회
  • 주요 과제

제7장 시장 세분화

  • 치료 기술별
    • 기기별
    • 외과적 시술별
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카(MEA)
    • 남미

제8장 경쟁 구도

  • 기업 인수합병(M&A) 분석
  • 합의, 협력, 제휴
  • 신제품 발매

제9장 주요 기업

  • AccuMED Corp
  • Apnea Sciences
  • Fisher & Paykel Healthcare Limited
  • Koninklijke Philips NV
  • Meditas
  • ResMed
  • SomnoMed
  • The Pure Sleep Company
  • Tomed GmbH
  • Whole You Inc.

제10장 시장 전망

LSH 18.07.13

The Global Anti-Snoring Market is expected to register a CAGR of nearly 10.60% during the forecast period.

As per a study titled, ''A systematic review of COVID-19 and obstructive sleep apnoea'', published in September 2020, which observes that obstructive sleep apnea may increase the risk of morbidity and mortality associated with COVID-19. Thus, such instances are expected to positively impact the demand for anti-snoring devices.

An increase in obesity and the geriatric population, increasing smoking and alcohol consumption, technological advancements in anti-snoring devices and increased awareness among the people are the key factors responsible for the growth of the market.

Weight gain is a major contributor to the habit of snoring because the peculiarities in weight gain are added in the elder population. According to a study titled, ''Obesity Prevalence in the Long-Term Future in 18 European Countries and in the USA'', published in October 2020, obesity is expected to reach maximum levels between the year 2030 and 2052 among men, and among women in the year 2026 and 2054. The Netherlands, USA, and UK, and Switzerland are likely to hit these maximum levels first. Thus, this rising burned of obesity among people is expected to boost the market growth over the forecast period.

Furthermore, the increasing number of geriatric population is also expected to contribute tremendously in the market growth. As per the World Ageing Population report, in 2019, about 702.9 million people living were aged 65 years and above and this number is expected to reach at 1,548.9 million by the year 2050. Thus, the aforementioned factors indicate that the increasing geriatric population and the rise in obesity are among the major factors for the growth of the anti-snoring market, globally.

Key Market Trends

Continuous Positive Airway Pressure (CPAP) Devices Sub-segment is Expected to Hold the Largest Market Share in the Devices Segment

In the devices segment of the anti-snoring market, the continuous positive airway pressure (CPAP) devices sub-segment is believed to have the largest market size. Amidst this pandemic situation, the demand for CPAP machines and masks is expected to rise since CPAP devices have shown beneficial effects on managing the symptoms of COVID-19, such as ease in breathing. As per a study titled, ''CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation'', in 2020, CPAP was found to be a potential tool in the treatment of early-stage COVID-19 patients.

Continuous positive airway pressure (CPAP) devices are used in cases of airway blockages, in order to open up the blocked airways by pushing air into them. The CPAP has a pump that controls the air pressure in the system and consists of a tube carrying air toward the mask attached to the nose and mouth. CPAP devices help in easing the functioning of the airway and help the person get a night of sound sleep, in turn, increasing their demand.

The companies are constantly engaged in the development of CPAP products via product innovation, mergers, acquisition, etc, in order to grow their presence in the market. This is expected to accelerate the market growth. For instance, in September 2020, CPAP Store USA, one of the pioneer in CPAP machines introduced it's own CPAP Store USA brand. It is a retail store that will be selling it's products including CPAP wipes, CPAP tubing, CPAP Filters, Chinstraps, CPAP machine travel bags and backpacks and others.

Also, in June 2019, InnAccel introduced SAANS, a CPAP system in the market. It is one of the world's first infrastructure-independent, portable and neonatal CPAP system that provides the constant flow of air, preventing the airway to collapse. Also, it eliminates the vibration of tissue that causes snoring. Hence, CPAP devices are expected to experience growth over the forecast period.

North America Dominates the Market and is Expected to do Same During the Forecast Period

North America currently dominates the anti-snoring market and is expected to continue its stronghold for a few more years. With the emergence of COVID-19, the market is expected to observe a positive impact. The study published in the American Journal of Respiratory and Critical Care Medicine, 2020, identified sleep apnea as one of the risk factors among COVID-19 patients. Such studies indicate the need for anti-snoring devices among these patients, as snoring is often associated with sleep apnea.

According to the data of Sleep Foundation, in the United States, in 2019, about 57% of the men and 40% of the women were living with the snoring condition. Furthermore, the rising obese population and the elderly population are also expected to fuel the market studied. According to the Centre for Disease Control and Prevention, 2019, the United States obesity rate was accounted to be approximately 42.4%, an increase of 26% since 2008. Thus, the rising patient population is boosting the regional market growth.

However, owing to new technologies that are constantly being developed pertaining to the market, the diagnosis of these snoring diseases has been effective and treatments are proving to be more helpful to patients. Thus, the rising awareness among patients regarding the effectiveness of anti-snoring devices and surgeries, and the easy availability of advanced detecting procedures across the world, are resulting in the increased demand for anti-snoring devices and surgeries.

Competitive Landscape

The anti-snoring market is majorly fragmented and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new ingredients with less prices. Companies, like Fisher & Paykel Healthcare Limited, Koninklijke Philips NV, ResMed, ASF Medical GmbH (Tomed GmbH), and Apnea Sciences hold a substantial market share in the global anti-snoring market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Obesity and Geriatric Population
    • 4.2.2 Increasing Smoking and Alcohol Consumption
    • 4.2.3 Technological Advancements in Anti-Snoring Devices
    • 4.2.4 Increased Awareness in the Developed Markets
  • 4.3 Market Restraints
    • 4.3.1 High Costs of Custom-made Oral Devices
    • 4.3.2 Poor Efficacy and Lack of Scientific Validation of the Anti-snoring Devices
    • 4.3.3 Social Stigma Associated with Snoring
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Treatment Technique
    • 5.1.1 By Device Types
      • 5.1.1.1 Mandibular Advancement Devices (MAD)
      • 5.1.1.2 Tongue Stabilizing Devices (TSD)
      • 5.1.1.3 Continuous Positive Airway Pressure (CPAP) Devices
      • 5.1.1.4 Other Device Types
    • 5.1.2 By Surgical Procedure
      • 5.1.2.1 Uvulopalatopharyngoplasty (UPPP)
      • 5.1.2.2 Somnoplasty
      • 5.1.2.3 Pillar Procedure
      • 5.1.2.4 Tonsillectomy
      • 5.1.2.5 Radiofrequency Palatoplasty
      • 5.1.2.6 Other Surgical Procedures
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Apnea Sciences
    • 6.1.2 ASF Medical GmbH (Tomed GmbH)
    • 6.1.3 Fisher & Paykel Healthcare Limited
    • 6.1.4 Koninklijke Philips NV
    • 6.1.5 Lear Corporation (AccuMED Corp.)
    • 6.1.6 Meditas
    • 6.1.7 Mitsui Chemicals (Whole You Inc.)
    • 6.1.8 ResMed
    • 6.1.9 SomnoMed
    • 6.1.10 The Pure Sleep Company
    • 6.1.11 Innovative Health Technologies
    • 6.1.12 GlaxoSmithKline
    • 6.1.13 Rotech Healthcare

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q